Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rugby Laboratories is a prominent American provider of generic and over-the-counter (OTC) pharmaceutical products, established in 1952. The company specializes in delivering high-quality, cost-effective alternatives to brand-name medications, with a portfolio spanning vitamins, supplements, and treatments for pain relief, allergies, and digestive health. After being acquired by Watson Pharmaceuticals in 1993 and later becoming part of The Harvard Drug Group, the Rugby brand was acquired by Cardinal Health in 2015. Today, it operates as a key commercial brand within Cardinal Health's distribution network, serving retail pharmacies, hospitals, and long-term care facilities across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rugby Pharmaceuticals.